Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1401 - 1422 of 1422

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1776 - 1800 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Trastuzumab emtansine for Metastatic Breast Cancer - Details	pcodr-provfund_kadcyla-mbc.pdf pcodr-kadcyla-mbc-fn-rec.pdf pcodr-kadcyla-mbc-fn-cgr.pdf pcodr-kadcyla-mbc-fn-egr.pdf pcodr-kadcyla-mbc-in-rec.pdf pcodr-kadcyla-mbc-pagfdk.pdf pcodr-kadcyla-mbc-fdk-roche.pdf pcodr-kadcyla-mbc-coi-cbcn.pdf pcodr-kadcyla-mbc-coi-rebc.pdf	Jan 27, 2014	Reimbursement Review	Complete	PC0024-000
Aripiprazole	cdr_SR0366_Abilify_Maintena.pdf SR0366_Abilify Maintena_CL_Report.pdf SR0366_Abilify Maintena_PE_Report.pdf SR0366_Abilify Maintena_PI_Submissions.pdf cdr_complete_SR0366_Abilify-Maintena_Dec-23-14.pdf	Jan 6, 2014	Reimbursement Review	Complete	SR0366-000
Adalimumab	cdr_SR0365_Humira.pdf	Dec 23, 2013	Reimbursement Review	Withdrawn	SR0365-000
Adcetris for systemic Anaplastic Large Cell Lymphoma - Details	pcodr-provfund_adcetris-salcl.pdf pcodr-adcetris-salcl-fn-rec.pdf pcodr-adcetris-salcl-fn-cgr.pdf pcodr-adcetris-salcl-fn-egr.pdf pcodr-adcetris-salcl-in-rec.pdf pcodr-adcetris-salcl-pagfdk.pdf pcodr-adcetris-salcl-coi-lfc.pdf	Dec 20, 2013	Reimbursement Review	Complete	PC0021-000
Tafinlar for Metastatic Melanoma - Details	pcodr-provfund_tafinlar-metmel.pdf pcodr-tafinlar-metmla-fn-rec.pdf pcodr-tafinlar-metmla-fn-cgr.pdf pcodr-tafinlar-metmla-fn-egr.pdf pcodr-tafinlar-metmla-in-rec.pdf pcodr-tafinlar-pag-fdk-in-rec.pdf pcodr-tafinlar-in-fdk-gsk.pdf pcodr-tafinlar-ptfdk-mnc.pdf pcodr-tafinlar-coi-mnc.pdf pcodr-tafinlar-ptfdk-sysf.pdf pcodr-tafinlar-coi-sysf.pdf	Dec 20, 2013	Reimbursement Review	Complete	PC0025-000
Macitentan	cdr_SR0364_Opsumit.pdf cdr_complete_SR0364_Opsumit_Jan-30-15.pdf SR0364_Opsumit_CL_Report_e.pdf SR0364_Opsumit_PE_Report_e.pdf SR0364_Opsumit_PI_e.pdf	Dec 18, 2013	Reimbursement Review	Complete	SR0364-000
Pemetrexed Alimta for Advanced Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) - Details	pcodr_provfund_alimta-nsclc.pdf pcodr-alimta-ns-nsclc-fn-rec.pdf pcodr-alimta-ns-nsclc-fn-cgr.pdf pcodr-alimta-ns-nsclc-fn-egr.pdf pcodr-alimta-ns-nsclc-in-rec.pdf pcodr-alimta-pagfdk-inrec.pdf pcodr-alimta-infdk-elilc.pdf pcodr-alimta-coi-ccsn.pdf pcodr-alimta-coi-lcc.pdf	Dec 5, 2013	Reimbursement Review	Complete	PC0027-000
Stivarga for Metastatic Colorectal Cancer - Details	pcodr_provfund_stivarga-mcrc.pdf pcodr-stivargamcrc-fn-rec.pdf pcodr-stivargamcrc-fn-cgr.pdf pcodr-stivargamcrc-fn-egr.pdf pcodr-stivargamcrc-in-rec.pdf pcodr-stivarga-mcrc-pagfdk-inr.pdf pcodr-stivarga-mcrc-fdk-bayer.pdf pcodr-stivarga-mcrc-ptfdk-ccac.pdf pcodr-stivarga-mcrc-coi-ccac.pdf	Dec 2, 2013	Reimbursement Review	Complete	PC0026-000
Mirabegron	cdr_SR0363_Myrbetriq.pdf cdr_complete_SR0363_Myrbetriq_nov14_2014.pdf SR0363_Myrbetriq_CL_Report_e.pdf SR0363_Myrbetriq_PE_Report_e.pdf SR0363_Myrbetriq_PI_Submissions_e.pdf	Nov 27, 2013	Reimbursement Review	Complete	SR0363-000
OnabotulinumtoxinA	cdr_SR0362_Botox_OAB.pdf cdr_complete_SR0362_Botox-OAB_nov14_2014.pdf SR0362_BotoxOAB_CL_Report_e.pdf SR0362_BotoxOAB_PE_Report_e.pdf SR0362_Botox OAB_PI_Submissions_e.pdf	Nov 25, 2013	Reimbursement Review	Complete	SR0362-000
Aflibercept	cdr_SR0361_Eylea.pdf cdr_complete_SR0361-000_eylea_october_22_2014.pdf SR0361_Eylea_CL_Report.pdf SR0361_Eylea_PE_Report.pdf SR0361_Eylea_PI_Submissions.pdf	Nov 18, 2013	Reimbursement Review	Complete	SR0361-000
Mekinist for Metastatic Melanoma - Details	pcodr_provfund_mekinist-metmel.pdf pcodr-mekinist-mm-fn-rec.pdf pcodr-mekinist-metmela-fn-cgr.pdf pcodr-mekinist-metmela-fn-egr.pdf pcodr-mekinist-metmela-in-rec.pdf pcodr-mekinist-pag-fdk-in-rec.pdf pcodr-mekinist-in-fdk-gsk.pdf pcodr-mekinist-in-fdk-mnc.pdf pcodr-mekinist-coi-mnc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0030-000
Revlimid for Multiple Myeloma - Details	pcodr_provfund_revlimid-mm.pdf pcodr-revlimid-mm-fn-rec.pdf pcodr-revlimid-mm-fn-cgr.pdf pcodr-revlimid-mm-fn-egr.pdf pcodr-revlimid-mm-in-rec.pdf pcodr-revlimid-pag-fdk-in-rec.pdf pcodr-revlimid-in-fdk-celgene.pdf pcodr-revlimid-coi-mc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0029-000
Zytiga for Metastatic Castration Resistant Prostate Cancer - Details	pcodr_profund_abiraterone_zytiga_mcrpc.pdf pcodr-zytiga-mcrpc-fn-rec.pdf pcodr-zytiga-mcrpc-fn-cgr.pdf pcodr-zytiga-mcrpc-fn-egr.pdf pcodr-zytiga-mcrpc-in-rec.pdf pcodr-zytiga-pag-fdk-in-rec.pdf pcodr-zytiga-in-fdk-janssen.pdf pcodr-zytiga-in-fdk-ccsn.pdf pcodr-zytiga-coi-ccsn.pdf pcodr-zytiga-in-fdk-pcc.pdf pcodr-zytiga-coi-pcc.pdf	Nov 6, 2013	Reimbursement Review	Complete	PC0028-000
Stiripentol	cdr_SR0360_Diacomit.pdf cdr_complete_SR0360_Diacomit_October_20_2014.pdf sr0360_diacomit_cl_report.pdf sr0360_diacomit_pe_report.pdf	Oct 30, 2013	Reimbursement Review	Complete	SR0360-000
Ustekinumab	cdr_SR0359_Stelara.pdf cdr_complete_SR0359_Stelara_Oct-22-14.pdf SR0359_Stelara_PE_Report.pdf SR0359_Stelara_CL_Report.pdf SR0359_Stelara_PI_Submissions.pdf	Oct 30, 2013	Reimbursement Review	Complete	SR0359-000
Fluticasone furoate /vilanterol	cdr_SR0358_Breo_Ellipta.pdf cdr_complete_breo_ellipta_august_20_2014.pdf SR0358_BreoEllipta_PE_Report.pdf SR0358_BreoEllipta_CL_Report.pdf	Oct 29, 2013	Reimbursement Review	Complete	SR0358-000
Dolutegravir	cdr_SR0357_Tivicay.pdf cdr_complete_tivicay_august_20_2014.pdf sr0357_tivicay_cl_report.pdf sr0357_tivicay_pe_report.pdf	Oct 18, 2013	Reimbursement Review	Complete	SR0357-000
Alemtuzumab	cdr_SR0355_Lemtrada.pdf	Oct 1, 2013	Reimbursement Review	Withdrawn	SR0355-000
Aripiprazole	cdr_SR0354_Abilify.pdf SR0354_AbilifyMDD_CL_Report_e.pdf SR0354_AbilifyMDD_PE_Report.pdf cdr_complete_SR0354_Abilify-MDD_Oct-24_2014.pdf	Oct 1, 2013	Reimbursement Review	Complete	SR0354-000
Sofosbuvir	cdr_SR0356_TBC_(Sofosbuvir).pdf SR0356_Sovaldi_CL_Report_e.pdf SR0356_Sovaldi_PE_Report_e.pdf cdr_complete_sovaldi_august_20_2014.pdf	Oct 1, 2013	Reimbursement Review	Complete	SR0356-000
Phleum pratense	cdr_SR0352_Grastek.pdf SR0352_Grastek_CL_Report_e.pdf SR0352_Grastek_PE_Report_e.pdf cdr_complete_SR0352_Grastek_sep-26_14.pdf	Sep 30, 2013	Reimbursement Review	Complete	SR0352-000
Riociguat	cdr_SR0353_Adempas.pdf SR0353_complete_Adempas_Jul-21-14.pdf SR0353_Adempas_CL_Report_e.pdf SR0353_Adempas_PE_Report-e.pdf	Sep 30, 2013	Reimbursement Review	Complete	SR0353-000
Adcetris for Hodgkin Lymphoma - Details	pcodr-provfund_adcetris-hl.pdf pcodr-adcetrishl-fn-rec.pdf pcodr-adcetrishl-fn-cgr.pdf pcodr-adcetrishl-fn-egr.pdf pcodr-adcetrishl-in-rec.pdf pcodr-adcetrishl-pag-fdk-inrec.pdf pcodr-adcetrishl-in-fdk-sg.pdf pcodr-adcetrishl-pt-fdk-lfc.pdf pcodr-adcetrishl-coi-lfc.pdf	Sep 17, 2013	Reimbursement Review	Complete	PC0020-000
Votrient for metastatic renal cell carcinoma - Resubmission - Details	pcodr-provfund_votrientmrcc-re.pdf pcodr-votrientmrccre-fn-rec.pdf pcodr-votrientmrccre-fn-cgr.pdf pcodr-votrientmrccre-fn-egr.pdf pcodr-votrientmrccre-in-rec.pdf pcodr-votrientmrccre-pag-fdbk.pdf pcodr-votrientmrccre-infdk-gsk.pdf pcodr-votrientmrccre-ptfdk-kcc.pdf pcodr-votrientmrccre-coi-kcc.pdf	Sep 17, 2013	Reimbursement Review	Complete	PC0022-000